fda restricted compounding bpc-157 restrictions on The FDA scheduled a hearing on peptides and the implications could be significant for prescribers and Repost @peptides with @use.repost ・・・

Repost @peptides with @use.repost BREAKING NEWS! Today's 86 advisory vote for BPC 157 is one of the biggest peptide regulatory developments we've seen in years. While nothing changes immediately, the recommendation represents FDA is reviewing seven peptides this week, BPC 157, MOTS c, and Epitalon among them. Committee meets Thursday and Friday, and the likely outcome is tighter restrictions on compounding pharmacies. Read past the headline NBC News The claims surrounding peptides are sweeping: They're promoted as treatments for everything from faster healing to younger looking skin, Instagram I am getting so many messages there is a lot to review and a lot unfolding quickly! I want to take my time with the information and have been studying on rotations. Hopefully will get yall an only A step towards expanded patient access. This will allow patients to have conversations about these compounds in the clinical setting instead of resorting to a gray market without practitioner oversight or monitoring!

SKU: 98603382708 · From crisbcreativa.com